Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Account Payables (2019 - 2023)

Historic Change in Account Payables for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $6.6 million.

  • ADC Therapeutics' Change in Account Payables rose 201687.09% to $6.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.2 million, marking a year-over-year increase of 92354.84%. This contributed to the annual value of $2.5 million for FY2024, which is 2240.78% down from last year.
  • Latest data reveals that ADC Therapeutics reported Change in Account Payables of $6.6 million as of Q4 2023, which was up 201687.09% from -$2.7 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Change in Account Payables ranged from a high of $6.6 million in Q4 2023 and a low of -$3.7 million during Q1 2023
  • In the last 5 years, ADC Therapeutics' Change in Account Payables had a median value of $3068.0 in 2021 and averaged $584930.1.
  • Over the last 5 years, ADC Therapeutics' Change in Account Payables had its largest YoY gain of 8729601.52% in 2023, and its largest YoY loss of 19620702.39% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Change in Account Payables stood at -$1684.0 in 2019, then surged by 313757.96% to $5.3 million in 2020, then tumbled by 99.97% to $1743.0 in 2021, then soared by 17709.01% to $310411.0 in 2022, then surged by 2016.87% to $6.6 million in 2023.
  • Its Change in Account Payables stands at $6.6 million for Q4 2023, versus -$2.7 million for Q3 2023 and $3.0 million for Q2 2023.